נגישות
menu      
Advanced Search
Syntax
Search...
Volcani treasures
About
Terms of use
Manage
Community:
אסיף מאגר המחקר החקלאי
Powered by ClearMash Solutions Ltd -
Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice
Year:
2004
Source of publication :
International Journal of Cancer
Authors :
Barash, Itamar
;
.
Volume :
112
Co-Authors:
Iavnilovitch, E., Institute of Animal Science, Agricultural Research Organization, Volcani Center, Bet-Dagan, Israel
Cardiff, R.D., Center of Comparative Medicine, University of California at Davis, Davis, CA, United States
Groner, B., Georg Speyer Haus, Institute for Biomedical Research, Frankfurt am Main, Germany
Barash, I., Institute of Animal Science, Agricultural Research Organization, Volcani Center, Bet-Dagan, Israel, Institute of Animal Science, ARO, Volcani Center, P.O. Box 6, Bet-Dagan 50250, Israel
Facilitators :
From page:
607
To page:
619
(
Total pages:
13
)
Abstract:
Members of the signal transducers and activators of transcription (Stat) family regulate essential cellular growth and survival functions in normal cells and have also been implicated in tumorigenesis. We have studied the potential role of Stat5 in mammary tumorigenesis by targeting Stat5 variants to the mammary gland of transgenic mice using regulatory sequences of the β-lactoglobulin gene. Mammary-directed expression of the wild-type Stat5, constitutively activated Stat5 and carboxyl-terminally truncated dominant negative Stat5 forms resulted in mammary tumors with incidence rates of up to 22% and latency periods of 8-12 months. Undifferentiated carcinomas most frequently occurred in mice expressing the carboxyl-terminally truncated Stat5. The more differentiated papillary and micropapillary adenocarcinomas were primarily found in mice overexpressing the native and constitutively active transgenes. Higher levels of translation initiation factor 4E (elF4E) and cyclin DI expression but lower levels of activated Stat5 were found in tumors of mice expressing the constitutively active Stat5 when compared to mice expressing the wild-type or truncated forms. A higher expression of the estrogen receptor (ERα) was observed in carcinomas compared to other phenotypes. The ability of both forms of Stat5, the transactivating form and the dominant negative form, to participate in oncogenesis indicates that there is more than one mechanism by which Stat5 contributes to this process. The transactivation function of Stat5 is involved in the determination of tumors with a more differentiated phenotype. © 2004 Wiley-Liss, Inc.
Note:
Related Files :
animal experiment
Animals
Cancer
carboxy terminal sequence
Female
mice
Oncogene
phenotype
Show More
Related Content
More details
DOI :
10.1002/ijc.20484
Article number:
Affiliations:
Database:
Scopus
Publication Type:
article
;
.
Language:
English
Editors' remarks:
ID:
29158
Last updated date:
02/03/2022 17:27
Creation date:
17/04/2018 00:44
You may also be interested in
Scientific Publication
Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice
112
Iavnilovitch, E., Institute of Animal Science, Agricultural Research Organization, Volcani Center, Bet-Dagan, Israel
Cardiff, R.D., Center of Comparative Medicine, University of California at Davis, Davis, CA, United States
Groner, B., Georg Speyer Haus, Institute for Biomedical Research, Frankfurt am Main, Germany
Barash, I., Institute of Animal Science, Agricultural Research Organization, Volcani Center, Bet-Dagan, Israel, Institute of Animal Science, ARO, Volcani Center, P.O. Box 6, Bet-Dagan 50250, Israel
Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice
Members of the signal transducers and activators of transcription (Stat) family regulate essential cellular growth and survival functions in normal cells and have also been implicated in tumorigenesis. We have studied the potential role of Stat5 in mammary tumorigenesis by targeting Stat5 variants to the mammary gland of transgenic mice using regulatory sequences of the β-lactoglobulin gene. Mammary-directed expression of the wild-type Stat5, constitutively activated Stat5 and carboxyl-terminally truncated dominant negative Stat5 forms resulted in mammary tumors with incidence rates of up to 22% and latency periods of 8-12 months. Undifferentiated carcinomas most frequently occurred in mice expressing the carboxyl-terminally truncated Stat5. The more differentiated papillary and micropapillary adenocarcinomas were primarily found in mice overexpressing the native and constitutively active transgenes. Higher levels of translation initiation factor 4E (elF4E) and cyclin DI expression but lower levels of activated Stat5 were found in tumors of mice expressing the constitutively active Stat5 when compared to mice expressing the wild-type or truncated forms. A higher expression of the estrogen receptor (ERα) was observed in carcinomas compared to other phenotypes. The ability of both forms of Stat5, the transactivating form and the dominant negative form, to participate in oncogenesis indicates that there is more than one mechanism by which Stat5 contributes to this process. The transactivation function of Stat5 is involved in the determination of tumors with a more differentiated phenotype. © 2004 Wiley-Liss, Inc.
Scientific Publication
You may also be interested in